Literature DB >> 7546400

CD23 and B-cell activation.

J Y Bonnefoy1, S Lecoanet-Henchoz, J P Aubry, J F Gauchat, P Graber.   

Abstract

The past year has seen the publication of significant new findings on the regulation of CD23 expression, the precise interaction of CD23 with CD21 and its functional consequences. Moreover, new advances have been made in unravelling the biochemical network of events downstream from the triggering of CD23 in human B cells. Analyses of the properties of CD23-deficient mice have demonstrated a link between IgE regulation and CD23 in vivo.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7546400     DOI： 10.1016/0952-7915(95)80110-3

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN： 0952-7915            Impact factor:   7.486


  19 in total

1.  Expression of CD27 and CD23 on peripheral blood B lymphocytes in humans of different ages.

Authors:  Dino Veneri; Riccardo Ortolani; Massimo Franchini; Giuseppe Tridente; Giovanni Pizzolo; Antonio Vella
Journal:  Blood Transfus       Date:  2009-01       Impact factor: 3.443

2.  Preventing abnormal NF-κB activation and autoimmunity by Otub1-mediated p100 stabilization.

Authors:  Yanchuan Li; Jin-Young Yang; Xiaoping Xie; Zuliang Jie; Lingyun Zhang; Jianhong Shi; Daniel Lin; Meidi Gu; Xiaofei Zhou; Haiyan S Li; Stephanie S Watowich; Antrix Jain; Sung Yun Jung; Jun Qin; Xuhong Cheng; Shao-Cong Sun
Journal:  Cell Res       Date:  2019-05-13       Impact factor: 25.617

Review 3.  Diversification of IgG effector functions.

Authors:  Stylianos Bournazos; Jeffrey V Ravetch
Journal:  Int Immunol       Date:  2017-07-01       Impact factor: 4.823

4.  Decreased levels of CD54 (ICAM-1)-positive lymphocytes in the peripheral blood in untreated patients with active juvenile dermatomyositis.

Authors:  M R O'Gorman; L Bianchi; D Zaas; V Corrochano; L M Pachman
Journal:  Clin Diagn Lab Immunol       Date:  2000-07

Review 5.  CD23 shedding: requirements for substrate recognition and inhibition by dipeptide hydroxamic acids.

Authors:  R J Mayer; P L Flamberg; S R Katchur; B J Bolognese; D G Smith; A E Marolewski; L A Marshall; A Faller
Journal:  Inflamm Res       Date:  2002-02       Impact factor: 4.575

6.  In vivo intranasal anti-CD23 treatment inhibits allergic responses in a murine model of allergic rhinitis.

Authors:  Minghui Zhou; Dongshu Du; Keqing Zhao; Chunquan Zheng
Journal:  J Mol Histol       Date:  2013-02-03       Impact factor: 2.611

7.  Distinct modulation by interferon-gamma (IFN-gamma) of CD23 expression on B and T lymphocytes of atopic subjects.

Authors:  M Corominas; M Mestre; J Bas; E Buendia
Journal:  Clin Exp Immunol       Date:  1998-05       Impact factor: 4.330

8.  CD23 (FcepsilonRII) release from cell membranes is mediated by a membrane-bound metalloprotease.

Authors:  A E Marolewski; D R Buckle; G Christie; D L Earnshaw; P L Flamberg; L A Marshall; D G Smith; R J Mayer
Journal:  Biochem J       Date:  1998-08-01       Impact factor: 3.857

Review 9.  Tissues: the unexplored frontier of antibody mediated immunity.

Authors:  Nicholas E Webb; Biana Bernshtein; Galit Alter
Journal:  Curr Opin Virol       Date:  2021-02-10       Impact factor: 7.090

10.  MiR-210 is induced by Oct-2, regulates B cells, and inhibits autoantibody production.

Authors:  Yingting Mok; Vera Schwierzeck; David C Thomas; Elena Vigorito; Tim F Rayner; Lorna B Jarvis; Haydn M Prosser; Allan Bradley; David R Withers; Inga-Lill Mårtensson; Lynn M Corcoran; Cherie Blenkiron; Eric A Miska; Paul A Lyons; Kenneth G C Smith
Journal:  J Immunol       Date:  2013-08-19       Impact factor: 5.422
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.